Company
CFO
CFO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Tim Sullivan has spoken on 10 earnings calls across 1 company, most recently on January 12, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
CFO
Source not stated
Recorded roles and call appearances connecting this person to public companies.
Company
CFO
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Apellis Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc. Q4 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc. Q3 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc. Q2 FY2024 Earnings Call
Apellis Pharmaceuticals, Inc. Q4 FY2023 Earnings Call
Apellis Pharmaceuticals, Inc. Q3 FY2023 Earnings Call
Apellis Pharmaceuticals, Inc. Q1 FY2023 Earnings Call
Apellis Pharmaceuticals, Inc. Q4 FY2021 Earnings Call
Apellis Pharmaceuticals, Inc. Q3 FY2021 Earnings Call